The
American Pharmaceutical Review is running a special feature marking the “50th
Anniversary of LAL Reagent Development”. The feature takes the form of a
roundtable discussion about the importance of LAL and its future development.
The
participants are:
- John Dubczak, General Manager, Charles River, Endotoxin and Microbial Detection
- Tim Sandle, Ph.D., Head of Microbiology, Bio Products Laboratory Ltd.
- Lakiya Wimbish, Product Manager, QC Testing Solutions Lonza Pharma&Biotech–Bioscience Solutions.
The article appears in the March 2014 edition (volume 17, issue 2).
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources